期刊文献+

经皮冠状动脉介入术中血栓抽吸治疗急性ST段抬高型心肌梗死的疗效观察 被引量:11

Effect of thrombus aspiration on acute ST-segment elevation myocardial infarction during percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨经皮冠状动脉介入术(PCI)中血栓抽吸治疗急性ST段抬高型心肌梗死(STEMI)的临床疗效。方法选择珠海市中西医结合医院心血管内科于2017年1月至2018年9月期间收治的91例STEMI患者为研究对象,根据随机数表法分为观察组(n=46)和对照组(n=45),对照组患者行常规PCI及支架置入治疗,观察组患者在PCI术中应用血栓抽吸技术,比较两组患者支架置入术后梗死相关血管TIMI血流分级情况,术后2 h的心电图ST段回落情况及术后7 d心脏彩超检查左室射血分数(LVEF),以及住院期间再发心肌梗死情况。结果观察组患者术后即刻TIMI血流Ⅲ级的比例和2 h ST段回落≥50%的比例分别为93.48%和91.30%,均明显高于对照组的82.22%和75.56%,术后即刻无复流的发生率为2.17%,明显低于对照组的15.56%,差异均有统计学意义(P<0.05);观察组患者术后LVEF为(63.25±7.24)%,明显高于对照组的(57.18±6.37)%,差异有统计学意义(P<0.05);观察组与对照组患者住院期间再发心梗发生率分别为2.17%和4.44%,差异无统计学意义(P>0.05)。结论急性ST段抬高型心肌梗死经皮冠状动脉介入术中血栓抽吸可以有效减少冠脉内血栓负荷,降低无复流现象的发生,提高PCI治疗成功率,改善患者的心功能。 Objective To investigate the clinical effect of thrombus aspiration in percutaneous coronary intervention(PCI) for acute ST-segment elevation myocardial infarction(STEMI). Methods A total of 91 STEMI patients,who treated in Internal Medicine-Cardiovascular Department of Zhuhai Integrated Chinese and Western Medicine Hospital from January 2017 to September 2018, were selected as the research subjects. According to the random number table method, they were divided into the observation group(n=46) and the control group(n=45). The patients in the control group were treated with routine PCI and stent implantation, and those in the observation group were treated with thrombus aspiration technique during PCI. The grading of TIMI blood flow in infarction-related vessels after stent implantation, ECG ST-segment depression >50% at 2 hours after stent implantation, left ventricular ejection fraction(LVEF) detected by color Doppler echocardiography at 7 days, and recurrent myocardial infarction during hospitalization were compared between the two groups. Results The proportion of TIMI blood flow grade Ⅲ and ST-segment depression(>50%) in the observation group were 93.48% and 91.30%, respectively, which were significantly higher than corresponding 82.22% and 75.56% in the control group;the no-reflow rate after operation was 2.17%, which was significantly lower than 15.56% in the control group(P<0.05). The LVEF in the observation group was(63.25±7.24)%, which was significantly higher than(57.18±6.37)% of the control group(P<0.05). There was no significant difference in the recurrent MI rate between the observation group and the control group during hospitalization(2.17% vs 4.44%, P>0.05). Conclusion Thrombus aspiration during PCI for STEMI can effectively reduce the thrombus load in coronary artery, reduce the occurrence of no-reflow, improve the success rate of PCI treatment and the cardiac function of patients.
作者 李军 夏小明 蒋齐勇 李志超 LI Jun;XIA Xiao-ming;JIANG Qi-yong;LI Zhi-chao(Department of Emergency,Zhuhai Integrated Chinese and Western Medicine Hospital,Zhuhai 519000,Guangdong,CHINA;Internal Medicine-Cardiovascular Department,Zhuhai Integrated Chinese and Western Medicine Hospital,Zhuhai 519000,Guangdong,CHINA)
出处 《海南医学》 CAS 2019年第3期301-303,共3页 Hainan Medical Journal
关键词 经皮冠状动脉介入术 血栓抽吸 急性ST段抬高型心肌梗死 无复流 心功能 疗效 Percutaneous coronary intervention(PCI) Thrombosuction Acute ST-segment elevation myocardial infarction(STEMI) No-reflow Cardiac function Curative effect
  • 相关文献

参考文献13

二级参考文献106

  • 1宋建华,梁彤,孙晨,王东雷.健康促进诊疗管理模式对社区慢性病的干预效果[J].中国全科医学,2009,12(12):1141-1142. 被引量:25
  • 2何喜民,向定成.冠状动脉痉挛的基础研究[J].国际心血管病杂志,2006,33(6):366-368. 被引量:9
  • 3YAN Hong-bing WANG Jian LI Nan ZHU Xiao-ling GAO Hai AI Hui LI Xiang YE Ming CHI Yun-peng ZHANG Hong.Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction:a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction[J].Chinese Medical Journal,2007(7):557-561. 被引量:29
  • 4周晓农,蔡黎,张小萍,盛慧锋,马杏宝,靳艳军,吴晓华,王显红,王龙英,林涛,申卫国,陆敬青,戴菁.上海市流动人口对血吸虫病传播的潜在危险性研究[J].中国寄生虫学与寄生虫病杂志,2007,25(3):180-184. 被引量:45
  • 5Salinas P, j imenez-Valero S, Moreno R, et al , Update in pharmacological management of coronary no-reflow phenomenon [J]. Cardiovasc Hematol Agents Med Chem,2012, 10(3): 256- 264.
  • 6Chan W, Stub D, Clark D J, et al , Usefulness of transient and persistent no-reflow to predict adverse clinical outcomes following percutaneous coronary intervention[J]. Am J Cardiol, 2012,109(4) :478-485.
  • 7O'Gara P T, Kushner F G, Ascheim D D, et al . 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2013,127 (4) : e362-e425.
  • 8Jeong Y H, Kim W J, Park D W, et al . Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction[J]. Int J Cardiol , 2010,141(2):175-181.
  • 9Akpek M, Kaya M G, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI[J]. Atherosclerosis, 2011,219(1) : 334- 341.
  • 10Basar N, Sen N, Ozcan F, et al . Elevated serum uric acid predicts angiographic impaired reperfusion and l-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention [J J. J Investig Med,2011.59(6) :931-937.

共引文献237

同被引文献111

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部